Hemodynamic control and clinical outcomes in the perioperative setting

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 3, 2011, Pages 509-525

  Aronson, Solomon ^a   Varon, Joseph ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

blood pressure; cardiac surgery; cardiovascular; hemodynamic control; hemodynamic management; morbidity; mortality; noncardiac surgery; perioperative; perioperative heart rate

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLEVIDIPINE; DILTIAZEM; DOBUTAMINE; DOPAMINE; ENALAPRILAT; ESMOLOL; FENOLDOPAM; GLYCERYL TRINITRATE; HYDRALAZINE; INOTROPIC AGENT; LABETALOL; METOPROLOL; MILRINONE; NICARDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; VERAPAMIL;

ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN HEMORRHAGE; BRONCHOSPASM; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CEREBROVASCULAR DISEASE; CYANIDE POISONING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG FEVER; DRUG HALF LIFE; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; ELECTIVE SURGERY; FATIGUE; FLUSHING; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPERBARIC OXYGEN; HYPERTENSION; HYPOTENSION; INJECTION SITE REACTION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FUNCTION TEST; LUNG TOXICITY; MEAN ARTERIAL PRESSURE; MORTALITY; NAUSEA; OXYGEN CONSUMPTION; PERIOPERATIVE PERIOD; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; SCALP PRURITUS; SIDE EFFECT; SINUS TACHYCARDIA; STROKE; SURGICAL MORTALITY; SURGICAL RISK; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPHYLAXIS; THYROID DISEASE; VERTIGO; VOMITING;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; HEMODYNAMICS; HUMANS; PERIOPERATIVE CARE; TREATMENT OUTCOME;

EID: 79957729512     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.01.018     Document Type: Review

References (172)

1. Braz LG, Braz DG, Cruz DS, et al: Mortality in anesthesia: A systematic review. Clinics (Sao Paulo) 64:999-1006, 2009
2. Arbous MS, Grobbee DE, van Kleef JW, et al: Mortality associated with anaesthesia: A qualitative analysis to identify risk factors. Anaesthesia 56:1141-1153, 2001 (Pubitemid 33103864)
3. Mangano DT: Peri-operative cardiovascular morbidity: New developments. Baillieres Clin Anaesthesiol 13:335-348, 1999
4. Mangano DT, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713-1720, 1996 (Pubitemid 26399345)
5. Basali A, Mascha EJ, Kalfas I, et al: Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiol 93:48-54, 2000 (Pubitemid 30436676)
6. Aronson S, Boisvert D, Lapp W: Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg 94:1079-1084, 2002 (Pubitemid 34441812)
7. Aronson S, Fontes ML, Miao Y, et al: Risk index for perioperative renal dysfunction/failure: Critical dependence on pulse pressure hypertension. Circulation 115:733-742, 2007 (Pubitemid 46294764)
8. Augoustides JG, Demers EA: Atrial fibrillation after cardiothoracic surgery: Incidence, risk factors, mechanisms, prevention and treatment. Prog Anesth 17:247-259, 2003
9. Boersma E, Kertai MD, Schouten O, et al: Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index. Am J Med 118:1134-1141, 2005 (Pubitemid 41363766)
10. Guzman M, Perez CM: Early postoperative complications after coronary artery bypass grafting at the Cardiovascular Center of Puerto Rico and the Caribbean. P R Health Sci J 17:353-357, 1998
11. Lee TH, Marcantonio ER, Mangione CM, et al: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043-1049, 1999 (Pubitemid 29416229)
12. Licker M, de Perrot M, Hohn L, et al: Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 15:314-319, 1999 (Pubitemid 29191476)
13. Reich DL, Bodian CA, Krol M, et al: Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 89:814-822, 1999 (Pubitemid 29458450)
14. Reich DL, Bennett-Guerrero E, Bodian CA, et al: Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg 95:273-277, 2002 (Pubitemid 34793082)
15. Aboyans V, Frank M, Nubret K, et al: Heart rate and pulse pressure at rest are major prognostic markers of early postoperative complications after coronary bypass surgery. Eur J Cardiothorac Surg 33:971-976, 2008
16. Benjo A, Thompson RE, Fine D, et al: Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension 50:630-635, 2007 (Pubitemid 47442725)
17. Fontes ML, Aronson S, Mathew JP, et al: Pulse pressure and risk of adverse outcome in coronary bypass surgery. Anesth Analg 107:1122-1129, 2008
18. Rady MY, Ryan T, Starr NJ: Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 26:225-235, 1998 (Pubitemid 28082682)
19. Wunderlich C, Gossrau G, Wunderlich E, et al: Distinct factors correlating with adverse cardiac events after major vascular surgery. Vasa 34:46-49, 2005 (Pubitemid 40321815)
20. Dutton RP: Definition of hemodynamic stability, in Wilson WC, Grande CM, Hoyt DB (eds). Trauma. Boca Raton, FL, CRC Press, 2007, p 145
21. Bailey J: Hemodynamic instability. Available at: http://clinicalwindow. net/cw-issue-15-article1.htm#. Accessed July 21, 2009
22. Poldermans D, Bax JJ, Boersma E, et al: Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J 30:2769-2812, 2009
23. Fleisher LA, Beckman JA, Brown KA, et al: 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 120:e169-e276, 2009
24. Brienza N, Giglio MT, Marucci M, et al: Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 37:2079-2090, 2009
25. Kern JW, Shoemaker WC: Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 30:1686-1692, 2002 (Pubitemid 34879575)
26. Polonen P, Ruokonen E, Hippelainen M, et al: A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90:1052-1059, 2000 (Pubitemid 30253449)
27. Domanski MJ, Davis BR, Pfeffer MA, et al: Isolated systolic hypertension: Prognostic information provided by pulse pressure. Hypertension 34:375-380, 1999 (Pubitemid 29426749)
28. Franklin SS, Khan SA, Wong ND, et al: Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham Heart Study. Circulation 100:354-360, 1999 (Pubitemid 29362404)
29. Klassen PS, Lowrie EG, Reddan DN, et al: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287:1548-1555, 2002 (Pubitemid 34270000)
30. Seshadri S, Wolf PA, Beiser A, et al: Elevated midlife blood pressure increases stroke risk in elderly persons: The Framingham Study. Arch Intern Med 161:2343-2350, 2001 (Pubitemid 32980133)
31. Wong ND, Thakral G, Franklin SS, et al: Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J 145:888-895, 2003 (Pubitemid 36570961)
32. Roach GW, Kanchuger M, Mangano CM, et al: Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 335:1857-1863, 1996
33. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560-2572, 2003 (Pubitemid 37430158)
34. National Heart, Lung, and Blood Institute. U.S. Department of Health and Human Services: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7 Guidelines). NIH Publication No. 04-5230. Available at: http://www.nhlbi.nih. gov/guidelines/hypertension/jnc7full.pdf. Accessed November 23, 2009
35. Laskowski ER. What's a normal heart rate? Available at: http://www.mayoclinic.com/health/heart-rate/AN01906. Accessed September 14, 2009
36. Fleischmann KE, Beckman JA, Buller CE, et al: 2009 ACCF/AHA focused update on perioperative beta blockade: A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 120:2123-2151, 2009
37. Monk TG, Saini V, Weldon BC, et al: Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 100:4-10, 2005 (Pubitemid 40013594)
38. Jeong DS, Kim KH, Kim JS, et al: Long-term experience of surgical treatment for aortic regurgitation attributable to Behcet's disease. Ann Thorac Surg 87:1775-1782, 2009
39. Rodriguez R, Robich MP, Plate JF, et al: Gastrointestinal complications following cardiac surgery: A comprehensive review. J Card Surg 25:188-197, 2010
40. Zhang X, Xu Z, Xu YQ, et al: Surgical intervention for advanced valvular heart disease in 227 cases. Chin Med J (Engl) 118:989-994, 2005 (Pubitemid 40903485)
41. Shoemaker WC, Wo CC, Thangathurai D, et al: Hemodynamic patterns of survivors and nonsurvivors during high risk elective surgical operations. World J Surg 23:1264-1270, 1999
42. Shoemaker WC, Appel PL, Kram HB: Hemodynamic and oxygen transport responses in survivors and nonsurvivors of high-risk surgery. Crit Care Med 21:977-990, 1993 (Pubitemid 23206188)
43. Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1717-1722, 1994 (Pubitemid 24171030)
44. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333:1025-1032, 1995
45. Cesanek P, Schwann N, Wilson E, et al: The effect of beta-blocker dosing strategy on regulation of perioperative heart rate and clinical outcomes in patients undergoing vascular surgery: a randomized comparison. Ann Vasc Surg 22:643-648, 2008
46. Devereaux PJ, Goldman L, Cook DJ, et al: Perioperative cardiac events in patients undergoing noncardiac surgery: A review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173:627-634, 2005 (Pubitemid 41345578)
47. Chopra V, Plaisance B, Cavusoglu E, et al: Perioperative beta-blockers for major noncardiac surgery: Primum Non Nocere. Am J Med 122:222-229, 2009
48. Goldberg ME, Larijani GE: Perioperative hypertension. Pharmacotherapy 18:911-914, 1998 (Pubitemid 28439980)
49. Varon J, Marik PE: Perioperative hypertension management. Vasc Health Risk Manag 4:615-627, 2008 (Pubitemid 352037919)
50. Smith MI: Preoperative Evaluation, Medical Management, and Critical Care. Philadelphia, PA, Lippincott Williams & Wilkins, 2005
51. Beattie WS, Wijeysundera DN, Karkouti K, et al: Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106:1039-1048, 2008 (Pubitemid 351450524)
52. Sander O, Welters ID, Foex P, et al: Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 33:81-88, 2005 (Pubitemid 40116540)
53. Gottesman RF, Hillis AE, Grega MA, et al: Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol 64:1111-1114, 2007 (Pubitemid 47258069)
54. Sramek BB: Systemic Hemodynamics and Hemodynamic Management. InstantPublisher.com; 2002. Available at: http://bomed.us/hembook.html. Accessed December 10, 2010
55. Lee KW, Blann AD, Lip GY: High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 18:104-115, 2005 (Pubitemid 40187356)
56. O'Rourke MF, Safar ME: Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension 46:200-204, 2005 (Pubitemid 40946514)
57. Murray WB, Foster PA: The peripheral pulse wave: Information overlooked. J Clin Monit 12:365-377, 1996
58. Mullan BA, Young IS, Fee H, et al: Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40:804-809, 2002 (Pubitemid 35434898)
59. Suleiman MS, Zacharowski K, Angelini GD: Inflammatory response and cardioprotection during open-heart surgery: The importance of anaesthetics. Br J Pharmacol 153:21-33, 2008
60. Wilkinson IB, Cockcroft JR: Mind the gap: Pulse pressure, cardiovascular risk, and isolated systolic hypertension. Am J Hypertens 13:1315-1317, 2000
61. Staessen JA, Gasowski J, Wang JG, et al: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355:865-872, 2000 (Pubitemid 30137665)
62. Mandinov L, Eberli FR, Seiler C, et al: Diastolic heart failure. Cardiovasc Res 45:813-825, 2000 (Pubitemid 30089643)
63. Clapp BR, Hingorani AD, Kharbanda RK, et al: Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 64:172-178, 2004 (Pubitemid 39208934)
64. Boyd AD, Tremblay RE, Spencer FC, et al: Estimation of cardiac output soon after intracardiac surgery with cardiopulmonary bypass. Ann Surg 150:613-626, 1959
65. Aronson S, Stafford-Smith M, Phillips-Bute B, et al: Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiol 113:305-312, 2010
66. Kobzar G, Mardla V, Ratsep I, et al: Platelet activity before and after coronary artery bypass grafting. Platelets 17:289-291, 2006 (Pubitemid 44277693)
67. Hennein HA, Ebba H, Rodriguez JL, et al: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108:626-635, 1994 (Pubitemid 24330237)
68. Richter Y, Edelman ER: Cardiology is flow. Circulation 113:2679-2682, 2006 (Pubitemid 43947984)
69. Fillinger MP, Surgenor SD, Hartman GS, et al: The association between heart rate and in-hospital mortality after coronary artery bypass graft surgery. Anesth Analg 95:1483-1488, 2002 (Pubitemid 35423929)
70. Jain U, Laflamme CJ, Aggarwal A, et al: Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiol 86:576-591, 1997
71. Yogaratnam JZ, Laden G, Guvendik L, et al: Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med 11:8-19, 2010
72. Charlson ME, MacKenzie CR, Gold JP, et al: Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann Surg 212:567-580, 1990
73. Devereaux PJ, Yang H, Yusuf S, et al: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 371:1839-1847, 2008
74. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al: Effects of intravenous fluid restriction on postoperative complications: Comparison of two perioperative fluid regimens: A randomized assessor-blinded multicenter trial. Ann Surg 238:641-648, 2003 (Pubitemid 38182252)
75. Nisanevich V, Felsenstein I, Almogy G, et al: Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiol 103:25-32, 2005 (Pubitemid 40943133)
76. Lobo DN, Bostock KA, Neal KR, et al: Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: A randomised controlled trial. Lancet 359:1812-1818, 2002
77. Mythen MG, Webb AR: Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 20:99-104, 1994 (Pubitemid 24120270)
78. Cohn LH, Powell MR, Seidlitz L, et al: Fluid requirements and shifts after reconstruction of the aorta. Am J Surg 120:182-186, 1970
79. Garnett RL, MacIntyre A, Lindsay P, et al: Perioperative ischaemia in aortic surgery: Combined epidural/general anaesthesia and epidural analgesia vs general anaesthesia and i.v. analgesia. Can J Anaesth 43:769-777, 1996 (Pubitemid 26273595)
80. Lang K, Boldt J, Suttner S, et al: Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 93:405-409, 2001 (Pubitemid 32701540)
81. Thompson JE, Vollman RW, Austin DJ, et al: Prevention of hypotensive and renal complications of aortic surgery using balanced salt solution: Thirteen-year experience with 670 cases. Ann Surg 167:767-778, 1968
82. Giglio MT, Marucci M, Testini M, et al: Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: A meta-analysis of randomized controlled trials. Br J Anaesth 103:637-646, 2009
83. Shoemaker WC, Appel PL, Kram HB, et al: Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94:1176-1186, 1988 (Pubitemid 19002776)
84. Reich DL, Wood RK Jr, Emre S, et al: Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth 17:699-702, 2003 (Pubitemid 38044896)
85. McGory ML, Maggard MA, Ko CY: A meta-analysis of perioperative beta blockade: What is the actual risk reduction? Surgery 138:171-179, 2005
86. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789-1794, 1999
87. Hemmerling TM, Olivier JF, Basile F, et al: Bispectral index as an indicator of cerebral hypoperfusion during off-pump coronary artery bypass grafting. Anesth Analg 100:354-356, 2005 (Pubitemid 40170522)
88. Landoni G, Turi S, Biondi-Zoccai G, et al: Esmolol reduces perioperative ischemia in noncardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 24:219-229, 2010
89. Zangrillo A, Turi S, Crescenzi G, et al: Esmolol reduces perioperative ischemia in cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 23:625-632, 2009
90. Ahuja K, Charap MH: Management of perioperative hypertensive urgencies with parenteral medications. J Hosp Med 5:E11-E16, 2010
91. Marik PE, Varon J: Hypertensive crises: Challenges and management. Chest 131:1949-1962, 2007
92. Schouten O, Shaw LJ, Boersma E, et al: A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 17:173-179, 2006 (Pubitemid 44366275)
93. Juul AB, Wetterslev J, Gluud C, et al: Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ 332:1482, 2006
94. Wijeysundera DN, Beattie WS: Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: A meta-analysis. Anesth Analg 97:634-641, 2003 (Pubitemid 37046419)
95. Basile J: The role of existing and newer calcium channel blockers in the treatment of hypertension. Available at: http://www.medscape.com/viewarticle/ 494334. Accessed October 12, 2009
96. Wijeysundera DN, Beattie WS, Rao V, et al: Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis. J Am Coll Cardiol 41:1496-1505, 2003 (Pubitemid 36543367)
97. Aronson S, Dyke CM, Stierer KA, et al: The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 107:1110-1121, 2008
98. Varon J, Marik PE: Clinical review: The management of hypertensive crises. Crit Care 7:374-384, 2003 (Pubitemid 37236308)
99. Friederich JA, Butterworth JF: Sodium nitroprusside: Twenty years and counting. Anesth Analg 81:152-162, 1995
100. Kondo T, Brock M, Bach H: Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn Heart J 25:231-237, 1984 (Pubitemid 14132585)
101. Niknahad H, O'Brien PJ: Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity. Biochem Pharmacol 51:1031-1039, 1996 (Pubitemid 26104625)
102. Robin ED, McCauley R: Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions. Chest 102:1842-1845, 1992
103. Landoni G, Biondi-Zoccai GG, Marino G, et al: Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: A meta-analysis. J Cardiothorac Vasc Anesth 22:27-33, 2008 (Pubitemid 351179395)
104. Ryckwaert F, Colson P, Ribstein J, et al: Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 86:169-175, 2001 (Pubitemid 32103403)
105. Turker H, Donmez A, Zeyneloglu P, et al: Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery. Anadolu Kardiyol Derg 4:296-300, 2004 (Pubitemid 39654410)
106. Brinkmann HM, Krier C, Fleischer F, et al: Combined use of dihydralazine and nitroglycerin during and after cardiac surgery. Anasth Intensivther Notfallmed 17:15-20, 1982 (Pubitemid 12113675)
107. Felker GM, Benza RL, Chandler AB, et al: Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study. J Am Coll Cardiol 41:997-1003, 2003 (Pubitemid 36315544)
108. Petersen JW, Felker GM: Inotropes in the management of acute heart failure. Crit Care Med 36:S106-S111, 2008
109. Toller WG, Metzler H: Acute perioperative heart failure. Curr Opin Anaesthesiol 18:129-135, 2005 (Pubitemid 40523224)
110. Donlan SM, Quattromani E, Pang PS, et al: Therapy for acute heart failure syndromes. Curr Cardiol Rep 11:192-201, 2009
111. Yamaguchi A, Tanaka M, Naito K, et al: The efficacy of intravenous milrinone in left ventricular restoration. Ann Thorac Cardiovasc Surg 15:233-238, 2009
112. Jebeli M, Ghazinoor M, Mandegar MH, et al: Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial. Cardiol J 17:73-78, 2010
113. Suttner S, Boldt J, Mengistu A, et al: Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients. Br J Anaesth 102:597-607, 2009
114. Stone MD, Wilson RJ, Cross J, et al: Effect of adding dopexamine to intraoperative volume expansion in patients undergoing major elective abdominal surgery. Br J Anaesth 91:619-624, 2003 (Pubitemid 37369520)
115. Burger AJ, Horton DP, LeJemtel T, et al: Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study. Am Heart J 144:1102-1108, 2002 (Pubitemid 36026926)
116. Packer M, Carver JR, Rodeheffer RJ, et al: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325:1468-1475, 1991
117. Thackray S, Easthaugh J, Freemantle N, et al: The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - A meta-regression analysis. Eur J Heart Fail 4:515-529, 2002 (Pubitemid 36564973)
118. Cuffe MS, Califf RM, Adams KF Jr, et al: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 287:1541-1547, 2002 (Pubitemid 34269999)
119. Fleming GA, Murray KT, Yu C, et al: Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation 118:1619-1625, 2008
120. Wang H, Gong M, Zhou B, et al: Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther 26:462-468, 2009
121. Entwistle JW III, McLoughlin DE, Baghelai K: Postoperative nesiritide use following high-risk mitral valve replacement. Heart Surg Forum 7:E189-E190, 2004
122. Feldman DS, Ikonomidis JS, Uber WE, et al: Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail 10:292-296, 2004 (Pubitemid 39092679)
123. Samuels LE, Holmes EC, Lee L: Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg 128:627-629, 2004 (Pubitemid 39278403)
124. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial JAMA 287:1531-1540, 2002
125. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491, 2005 (Pubitemid 40470642)
126. Aaronson KD, Sackner-Bernstein J: Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA 296:1465-1466, 2006 (Pubitemid 44465509)
127. Mentzer RM Jr, Oz MC, Sladen RN, et al: Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol 49:716-726, 2007 (Pubitemid 46205038)
128. Dyke CM, Bhatia D, Aronson S, et al: Perioperative nesiritide and possible renal protection in patients with moderate to severe kidney dysfunction. J Thorac Cardiovasc Surg 136:1369-1370, 2008
129. Salmenpera M, Eriksson H: Levosimendan in perioperative and critical care patients. Curr Opin Anaesthesiol 22:496-501, 2009
130. Soeding PE, Royse CF, Wright CE, et al: Inoprotection: The perioperative role of levosimendan. Anaesth Intensive Care 35:845-862, 2007 (Pubitemid 350248084)
131. Raja SG, Rayen BS: Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 81:1536-1546, 2006
132. Eriksson HI, Jalonen JR, Heikkinen LO, et al: Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 87:448-454, 2009
133. Tritapepe L, De Santis V, Vitale D, et al: Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102:198-204, 2009
134. De Hert SG, Lorsomradee S, vanden Eede H, et al: A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 22:699-705, 2008
135. Ponschab M, Hochmair N, Ghazwinian N, et al: Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Eur J Anaesthesiol 25:627-633, 2008 (Pubitemid 351914991)
136. National Institutes of Health: Clinical trials: levosimendan. Available at: http://www.clinicaltrials.gov/ct2/results?term=levosimendan. Accessed November 5, 2010
137. Widlansky ME, Gokce N, Keaney JF Jr, et al: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149-1160, 2003 (Pubitemid 37188333)
138. O'Rourke MF, Hashimoto J: Mechanical factors in arterial aging: A clinical perspective. J Am Coll Cardiol 50:1-13, 2007 (Pubitemid 46963521)
139. Cheung AT: Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 21:S8-S14, 2006 (suppl 1)
140. Benetos A, Thomas F, Safar ME, et al: Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: A study in middle-aged men and women. J Am Coll Cardiol 37:163-168, 2001 (Pubitemid 32051733)
141. Stone JG, Foex P, Sear JW, et al: Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiol 68:495-500, 1988
142. Raby KE, Brull SJ, Timimi F, et al: The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477-482, 1999 (Pubitemid 29109006)
143. Urban MK, Markowitz SM, Gordon MA, et al: Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90:1257-1261, 2000 (Pubitemid 30351320)
144. Magnusson H, Ponten J, Sonander HG: Methohexitone anaesthesia for microlaryngoscopy: Circulatory modulation with metoprolol and dihydralazine. Br J Anaesth 58:976-982, 1986 (Pubitemid 16013377)
145. Pasternack PF, Grossi EA, Baumann FG, et al: Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 158:113-116, 1989 (Pubitemid 19206329)
146. Rosenberg J, Overgaard H, Andersen M, et al: Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography. BMJ 313:258-261, 1996 (Pubitemid 26254731)
147. Caramella JP, Goursot G, Carcone B, et al: Prevention of perand postoperative myocardial ischemia in non-cardiac surgery by intravenous diltiazem. Ann Fr Anesth Reanim 7:245-250, 1988
148. Colson P, Medioni P, Saussine M, et al: Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery. J Cardiothorac Vasc Anesth 6:424-428, 1992
149. Garcia-Guasch R, Llubia C, Preciado MJ, et al: Diltiazem compared with placebo in the prevention of myocardial ischemia during non-cardiac surgery. Rev Esp Anestesiol Reanim 45:409-415, 1998 (Pubitemid 29017215)
150. Godet G, Coriat P, Baron JF, et al: Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: A randomized trial versus placebo. Anesthesiol 66:241-245, 1987 (Pubitemid 17014463)
151. Lindgren L, Lepantalo M, von Knorring J, et al: Effect of verapamil on right ventricular pressure and atrial tachyarrhythmia after thoracotomy. Br J Anaesth 66:205-211, 1991
152. Zaugg M, Tagliente T, Lucchinetti E, et al: Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91:1674-1686, 1999
153. Brady AR, Gibbs JS, Greenhalgh RM, et al: Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 41:602-609, 2005
154. Pasternack PF, Imparato AM, Baumann FG, et al: The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76:III1-III7, 1987
155. Amar D, Roistacher N, Burt ME, et al: Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg 63:1374-1381, 1997
156. Liu PL, Gatt S, Gugino LD, et al: Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine. Can Anaesth Soc J 33:556-562, 1986 (Pubitemid 16022430)
157. Oxorn D, Knox JW, Hill J: Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Can J Anaesth 37:206-209, 1990 (Pubitemid 20091611)
158. Coleman AJ, Jordan C: Cardiovascular responses to anaesthesia. Influence of beta-adrenoreceptor blockade with metoprolol. Anaesthesia 35:972-978, 1980
159. The Esmolol Research Group: Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: Results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. Am Heart J 112:498-505, 1986
160. Amar D, Roistacher N, Rusch VW, et al: Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg 120:790-798, 2000
161. Shimada M, Namai H, Morisaki H, et al: Preventive use of diltiazem to suppress supraventricular tachyarrhythmia in the patients after esophagectomy. Masui 46:658-663, 1997 (Pubitemid 27242023)
162. van Mieghem W, Tits G, Demuynck K, et al: Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann Thorac Surg 61:1083-1085, 1996
163. Feng CK, Chan KH, Liu KN, et al: A comparison of lidocaine, fentanyl, and esmolol for attenuation of cardiovascular response to laryngoscopy and tracheal intubation. Acta Anaesthesiol Sin 34:61-67, 1996
164. Retamal O, Coriat P, Pamela F, et al: Prevention of hypertensive attacks after carotid surgery. The value of nifedipine and diltiazem. Ann Fr Anesth Reanim 5:278-286, 1986
165. Wallace A, Layug B, Tateo I, et al: Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiol 88:7-17, 1998 (Pubitemid 128721126)
166. Poldermans D, Bax JJ, Schouten O, et al: Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48:964-969, 2006
167. Gottlieb SO, Weisfeldt ML, Ouyang P, et al: Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 10:756-760, 1987 (Pubitemid 17163098)
168. Mangano DT, Wong MG, London MJ, et al: Perioperative myocardial ischemia in patients undergoing noncardiac surgery - II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 17:851-857, 1991
169. Cleviprex [package insert]. Clayton, NC, Hospira Inc, 2008
170. Awad AS, Goldberg ME: Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. Vasc Health Risk Manag 6:457-464, 2010
171. Peacock WF, Angeles JE, Soto KM, et al: Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: A review. Ther Clin Risk Manag 5:627-634, 2009
172. Piccini JP, Berger JS, O'Connor CM: Amiodarone for the prevention of sudden cardiac death: A meta-analysis of randomized controlled trials. Eur Heart J 30:1245-1253, 2009